The growth of Endoscope Reprocessing Market is driven by increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities.
According to the new market research report “Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, AER (Portable, Standalone), Endoscope Tracking Solutions, Endoscope Drying, Storage, & Transport Systems), End User (Hospitals, ASCs & Clinics) – Global Forecast to 2026”, published by MarketsandMarkets™, the global market is projected to reach USD 3.2 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 9.0% from 2021 to 2026.
– In 2021, Getinge partnered with researchers from the School of Business, Economics and Law at the University of Gothenburg, Sweden, on customer-centric innovation and sustainability. This will help the company gain access to the researchers’ socially relevant and applicable knowledge.
– In 2021, Getinge opened a new Customer Experience Center to interact with and support customers.
– In 2020, STERIS entered into a definitive agreement to acquire Cantel through a US subsidiary. The acquisition will enable STERIS to offer a broader set of Customers a more diversified selection of infection prevention and procedural products and services.
Download PDF Brochure:
“High-level disinfectants and test strips are expected to hold the largest share of the market, by product in 2021.”
Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2020, the high-level disinfectants and test strips segment accounted for the largest share of the global market. The large share of this segment can be attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.
“Hospitals are expected to hold the largest share of the endoscope reprocessing market, by end user in 2021.”
Based on end users, the global market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2020, the hospitals segment accounted for the largest share of the global market. The large share of this segment can be attributed to the increasing government & private funding, growth in the healthcare sector in emerging economies, increasing out-of-pocket healthcare expenditure worldwide, and the increasing number of endoscopic procedures performed.
Request Sample Pages:
Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America commanded the largest share of the market. The large share of this market segment can be attributed to factors such as the rising incidence of cancer, favorable reimbursement scenarios, and increasing incidence of endoscope-related infections.
The major players operating in this endoscope reprocessing market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), Medalkan (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).
Speak To Analyst: www.marketsandmarkets.com/speaktoanalystNew.asp?id=219094994